These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7692899)

  • 1. Autotransfusion of shed blood contributes additionally to blood saving in patients receiving aprotinin (2 million KIU).
    Schönberger JP; Bredée J; Speekenbrink RG; Everts PA; Wildevuur CR
    Eur J Cardiothorac Surg; 1993; 7(9):474-7. PubMed ID: 7692899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood loss and use of blood in internal mammary artery and saphenous vein bypass grafting with and without adding a single, low-dose of aprotinin (2 million units) to the pump prime.
    Schönberger JP; van Zundert A; Bredée JJ; Gardien M; Everts PA; Bavinck JH; Berreklouw E; Wildevuur CR
    Acta Anaesthesiol Belg; 1992; 43(3):187-96. PubMed ID: 1280395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of ultra-low-dose aprotinin to reduce blood loss in cardiac surgery.
    Alvarez JM; Quiney NF; McMillan D; Joscelyne K; Connelly T; Brady P; Deal C; Wilson R
    J Cardiothorac Vasc Anesth; 1995 Feb; 9(1):29-33. PubMed ID: 7536481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraoperative antifibrinolysis and blood-saving techniques in cardiac surgery. Prospective trial of 3 antifibrinolytic drugs.
    Penta de Peppo A; Pierri MD; Scafuri A; De Paulis R; Colantuono G; Caprara E; Tomai F; Chiariello L
    Tex Heart Inst J; 1995; 22(3):231-6. PubMed ID: 7580360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of aprotinin on blood loss and blood transfusion in off-pump coronary artery bypass grafting.
    Bittner HB; Lemke J; Lange M; Rastan A; Mohr FW
    Ann Thorac Surg; 2008 May; 85(5):1662-8. PubMed ID: 18442562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Reduction of postoperative blood loss and donor blood use in heart surgery with aprotinin: experience with various dosages].
    Carrel T; Bauer E; Garcia E; von Segesser L; Niederhäuser U; Schönbeck M; Laske A; Turina M
    Helv Chir Acta; 1991 Sep; 58(3):365-78. PubMed ID: 1722785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose aprotinin in internal mammary artery bypass operations contributes to important blood saving.
    Schönberger JP; Everts PA; Ercan H; Bredée JJ; Bavinck JH; Berreklouw E; Wildevuur CR
    Ann Thorac Surg; 1992 Dec; 54(6):1172-6. PubMed ID: 1280412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of a blood conservation program including low-dose aprotinin in routine myocardial revascularization.
    Schönberger JP; Woolley S; Tavilla G; Berreklouw E; Bredée JJ; Mashhour YA; Van Straten BH; Bavinck JH; Frietman PA; Everts PA; Wildevuur ChR
    J Cardiovasc Surg (Torino); 1996 Feb; 37(1):35-44. PubMed ID: 8606206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical use of aprotinin in coronary artery bypass surgery.
    Mand'ák J; Lonský V; Dominik J
    Acta Medica (Hradec Kralove); 1999; 42(4):139-44. PubMed ID: 10812681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative therapy of low-dose aspirin in internal mammary artery bypass operations with and without low-dose aprotinin.
    Schönberger JP; Bredée JJ; van Oeveren W; van Zundert AA; Verkroost M; Terwoorst J; Bavinck JH; Berreklouw E; Wildevuur CR
    J Thorac Cardiovasc Surg; 1993 Aug; 106(2):262-7. PubMed ID: 7688059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of postoperative normovolaemic anaemia and autotransfusion on blood saving after internal mammary artery bypass surgery.
    Schönberger JP; Everts PA; Bredee JJ; Jansen E; Goedkoop R; Bavinck JH; Berreklouw E; Wildevuur CR
    Perfusion; 1992; 7(4):257-62. PubMed ID: 10148022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultra-low dose aprotinin decreases transfusion requirements and is cost effective in coronary operations.
    Dignan RJ; Law DW; Seah PW; Manganas CW; Newman DC; Grant PW; Wolfenden HD
    Ann Thorac Surg; 2001 Jan; 71(1):158-63; discussion 163-4. PubMed ID: 11216738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraoperative autotransfusion reduces blood loss after cardiopulmonary bypass.
    Kochamba GS; Pfeffer TA; Sintek CF; Khonsari S
    Ann Thorac Surg; 1996 Mar; 61(3):900-3. PubMed ID: 8619714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-dose heparin versus full-dose heparin with high-dose aprotinin during cardiopulmonary bypass. A preliminary report.
    von Segesser LK; Garcia E; Turina MI
    Tex Heart Inst J; 1993; 20(1):28-32. PubMed ID: 7685221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autotransfusion after coronary artery bypass grafting halves the number of patients needing blood transfusion.
    Schmidt H; Mortensen PE; Følsgaard SL; Jensen EA
    Ann Thorac Surg; 1996 Apr; 61(4):1177-81. PubMed ID: 8607679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraoperative predonation contributes to blood saving.
    Schönberger JP; Bredée JJ; Tjian D; Everts PA; Wildevuur CR
    Ann Thorac Surg; 1993 Oct; 56(4):893-8. PubMed ID: 8105759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the effects of a cell saver and low-dose aprotinin on blood loss and homologous blood usage in patients undergoing valve surgery.
    Tempe DK; Banerjee A; Virmani S; Mehta N; Panwar S; Tomar AS; Ghambeer DK; Nigam M
    J Cardiothorac Vasc Anesth; 2001 Jun; 15(3):326-30. PubMed ID: 11426363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A comparison of autologous transfusion procedures in hip surgery].
    Lorentz A; Osswald PM; Schilling M; Jani L
    Anaesthesist; 1991 Apr; 40(4):205-13. PubMed ID: 2058822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Consistent non-pharmacologic blood conservation in primary and reoperative coronary artery bypass grafting.
    Ovrum E; Am Holen E; Tangen G
    Eur J Cardiothorac Surg; 1995; 9(1):30-5. PubMed ID: 7727143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mini-dose pump-prime aprotinin inhibited enhanced fibrinolytic activity and reduced blood loss and transfusion requirements after coronary artery bypass surgery.
    Kunt AS; Darcin OT; Aydin S; Demir D; Selli C; Andac MH
    J Thromb Thrombolysis; 2005 Jun; 19(3):197-200. PubMed ID: 16082607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.